115 related articles for article (PubMed ID: 10707260)
1. Antituberculosis activity of certain antifungal and antihelmintic drugs.
Sun Z; Zhang Y
Tuber Lung Dis; 1999; 79(5):319-20. PubMed ID: 10707260
[TBL] [Abstract][Full Text] [Related]
2. Studies of antituberculosis chemotherapy with an in vitro model of human tuberculosis.
Crowle AJ
Semin Respir Infect; 1986 Dec; 1(4):262-4. PubMed ID: 3120268
[TBL] [Abstract][Full Text] [Related]
3. Bactericidal activity of 2-nitroimidazole against the active replicating stage of Mycobacterium bovis BCG and Mycobacterium tuberculosis with intracellular efficacy in THP-1 macrophages.
Khan A; Sarkar S; Sarkar D
Int J Antimicrob Agents; 2008 Jul; 32(1):40-5. PubMed ID: 18538548
[TBL] [Abstract][Full Text] [Related]
4. Agelasine F from a Philippine Agelas sp. sponge exhibits in vitro antituberculosis activity.
Mangalindan GC; Talaue MT; Cruz LJ; Franzblau SG; Adams LB; Richardson AD; Ireland CM; Concepcion GP
Planta Med; 2000 May; 66(4):364-5. PubMed ID: 10865457
[TBL] [Abstract][Full Text] [Related]
5. In vitro and ex vivo activity of thioridazine derivatives against Mycobacterium tuberculosis.
Martins M; Schelz Z; Martins A; Molnar J; Hajös G; Riedl Z; Viveiros M; Yalcin I; Aki-Sener E; Amaral L
Int J Antimicrob Agents; 2007 Mar; 29(3):338-40. PubMed ID: 17239569
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of new enantiomerically pure azole derivatives as inhibitors of Mycobacterium tuberculosis.
Castagnolo D; Radi M; Dessì F; Manetti F; Saddi M; Meleddu R; De Logu A; Botta M
Bioorg Med Chem Lett; 2009 Apr; 19(8):2203-5. PubMed ID: 19299129
[TBL] [Abstract][Full Text] [Related]
7. In vitro antituberculosis activities of the constituents isolated from Haloxylon salicornicum.
Bibi N; Tanoli SA; Farheen S; Afza N; Siddiqi S; Zhang Y; Kazmi SU; Malik A
Bioorg Med Chem Lett; 2010 Jul; 20(14):4173-6. PubMed ID: 20542692
[TBL] [Abstract][Full Text] [Related]
8. [Studies on the effect of antituberculosis agents against tubercle bacilli in the resting state, using streptomycin-dependent strain (18-b). I. Studies in vitro].
Ota Y
Kekkaku; 1971 Aug; 46(8):295-301. PubMed ID: 4328204
[No Abstract] [Full Text] [Related]
9. Synthesis of novel [1,2]-diamines with antituberculosis activity.
Meng Q; Luo H; Chen Y; Wang T; Yao Q
Bioorg Med Chem Lett; 2009 Sep; 19(18):5372-5. PubMed ID: 19682895
[TBL] [Abstract][Full Text] [Related]
10. In vitro and ex vivo activity of new derivatives of acetohydroxyacid synthase inhibitors against Mycobacterium tuberculosis and non-tuberculous mycobacteria.
Sohn H; Lee KS; Ko YK; Ryu JW; Woo JC; Koo DW; Shin SJ; Ahn SJ; Shin AR; Song CH; Jo EK; Park JK; Kim HJ
Int J Antimicrob Agents; 2008 Jun; 31(6):567-71. PubMed ID: 18337064
[TBL] [Abstract][Full Text] [Related]
11. Antituberculosis agents. VI. Activity of a new ciprofloxacin derivative against Mycobacterium avium and some drug-resistant strains of Mycobacterium tuberculosis.
Foroumadi A; Soltani F; Moshafi MH
Boll Chim Farm; 2002; 141(5):394-6. PubMed ID: 12481384
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antituberculosis activity of a novel series of optically active 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles.
Sasaki H; Haraguchi Y; Itotani M; Kuroda H; Hashizume H; Tomishige T; Kawasaki M; Matsumoto M; Komatsu M; Tsubouchi H
J Med Chem; 2006 Dec; 49(26):7854-60. PubMed ID: 17181168
[TBL] [Abstract][Full Text] [Related]
13. Preparation and in vitro evaluation of benzylsulfanyl benzoxazole derivatives as potential antituberculosis agents.
Klimesová V; Kocí J; Waisser K; Kaustová J; Möllmann U
Eur J Med Chem; 2009 May; 44(5):2286-93. PubMed ID: 18694614
[TBL] [Abstract][Full Text] [Related]
14. In vitro inhibitory effect of antituberculosis drugs on clinical and environmental strains of Coccidioides posadasii.
de Aguiar Cordeiro R; Brilhante RS; Rocha MF; Fechine MA; Camargo ZP; Sidrim JJ
J Antimicrob Chemother; 2006 Sep; 58(3):575-9. PubMed ID: 16867997
[TBL] [Abstract][Full Text] [Related]
15. Antituberculosis agents, I: Synthesis and antituberculosis activity of 2-aryl-1,3,4-thiadiazole derivatives.
Foroumadi A; Mirzaei M; Shafiee A
Pharmazie; 2001 Aug; 56(8):610-2. PubMed ID: 11534334
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vitro antitubercular activity of a series of quinoline derivatives.
de Souza MV; Pais KC; Kaiser CR; Peralta MA; de L Ferreira M; Lourenço MC
Bioorg Med Chem; 2009 Feb; 17(4):1474-80. PubMed ID: 19188070
[TBL] [Abstract][Full Text] [Related]
17. Minimal inhibitory concentrations of lomefloxacin and minocycline against drug-sensitive and drug-resistant isolates of M. tuberculosis compared on L-J and 7H11 media.
Kamala T; Herbert D; Venkatesan P; Paramasivan CN
Int J Lepr Other Mycobact Dis; 1997 Sep; 65(3):375-8. PubMed ID: 9401493
[TBL] [Abstract][Full Text] [Related]
18. Novel N-aryl- and N-heteryl phenazine-1-carboxamides as potential agents for the treatment of infections sustained by drug-resistant and multidrug-resistant Mycobacterium tuberculosis.
De Logu A; Palchykovska LH; Kostina VH; Sanna A; Meleddu R; Chisu L; Alexeeva IV; Shved AD
Int J Antimicrob Agents; 2009 Mar; 33(3):223-9. PubMed ID: 19070992
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vitro anti Mycobacterium tuberculosis activity of a series of phthalimide derivatives.
Santos JL; Yamasaki PR; Chin CM; Takashi CH; Pavan FR; Leite CQ
Bioorg Med Chem; 2009 Jun; 17(11):3795-9. PubMed ID: 19427791
[TBL] [Abstract][Full Text] [Related]
20. [A supplement study on the in vitro activity of sulfadimethoxine on Mycobacterium avium complex--combined effect with other antituberculosis drugs].
Tsukamura M
Kekkaku; 1989 Jun; 64(6):379-86. PubMed ID: 2507819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]